Showing results (161-170 of 3,869) with videos related to
Sort By:
Pageof 387
Fortschritte Der Neurologie-Psychiatrie|June 6, 2014
[Adult ADHD versus borderline personality disorder: criteria for differential diagnosis]O Witt, K Brücher, G Biegel, et al.Journal of Bacteriology|September 18, 2007
Dissection of the caffeate respiratory chain in the acetogen Acetobacterium woodii: identification of an Rnf-type NADH dehydrogenase as a potential coupling siteFrank Imkamp, Eva Biegel, Elamparithi Jayamani, et al.The Gerontologist|February 1, 1989
Unmet needs and barriers to service delivery for the blind and visually impaired elderlyD E Biegel, M K Petchers, A Snyder, et al.Acta Chirurgiae Orthopaedicae Et Traumatologiae Cechoslovaca|November 15, 2001
[The Zweymuller endoprosthesis in hip joint revision surgery]V Stĕdrý, P Dungl, P Hajný, et al.Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|June 1, 1983
Spirogermanium: effects on hematopoietic stem cells and survival of normal and tumor-bearing miceG N Schwartz, J A Biegel, B Fisher, et al.Annals of the New York Academy of Sciences|April 2, 2008
Discovery of a ferredoxin:NAD+-oxidoreductase (Rnf) in Acetobacterium woodii: a novel potential coupling site in acetogensVolker Müller, Frank Imkamp, Eva Biegel, et al.Journal of Medicinal Chemistry|July 11, 2006
Structural requirements for the substrates of the H+/peptide cotransporter PEPT2 determined by three-dimensional quantitative structure-activity relationship analysisAnnegret Biegel, Sabine Gebauer, Matthias Brandsch, et al.Toxicology|February 1, 1989
6-Methyl-1,3,8-trichlorodibenzofuran (MCDF) as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist in C57BL/6 miceR Bannister, L Biegel, D Davis, et al.Journal of Inflammation Research|March 20, 2026
The Role of Galectin-3 in Liver Inflammation and FibrosisIsabella Lurje, Dina Katharina Biegel, Ingrid Wei Zhang, et al.The Medical Journal of Australia|May 20, 1996
Managing HIV. Part 5: Treating secondary outcomes. 5.18 HIV and sexually transmitted diseasesD C Plummer, V FurnerPageof 387